Poplack DG - Search Results

1

Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.

Walsh TJ, Lester-McCully C, Rinaldi MG, Wallace JE, Balis FM, Lee JW, Pizzo PA, Poplack DG. Walsh TJ, et al. Among authors: poplack dg. Antimicrob Agents Chemother. 1990 Jun;34(6):1281-4. doi: 10.1128/AAC.34.6.1281. Antimicrob Agents Chemother. 1990. PMID: 2393291 Free PMC article.

2

Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates.

Heideman RL, Balis FM, McCully C, Poplack DG. Heideman RL, et al. Among authors: poplack dg. Cancer Res. 1988 Aug 1;48(15):4294-8. Cancer Res. 1988. PMID: 2455594

3

Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys.

Balis FM, McCully C, Gough L, Pizzo PA, Poplack DG. Balis FM, et al. Among authors: poplack dg. Antimicrob Agents Chemother. 1989 Jun;33(6):810-2. doi: 10.1128/AAC.33.6.810. Antimicrob Agents Chemother. 1989. PMID: 2764527 Free PMC article.

4

Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.

Arndt CA, Walsh TJ, McCully CL, Balis FM, Pizzo PA, Poplack DG. Arndt CA, et al. Among authors: poplack dg. J Infect Dis. 1988 Jan;157(1):178-80. doi: 10.1093/infdis/157.1.178. J Infect Dis. 1988. PMID: 2826606 No abstract available.

5

Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome.

Rogers P, Allegra CJ, Murphy RF, Drake JC, Masur H, Poplack DG, Chabner BA, Parrillo JE, Lane HC, Balis FM. Rogers P, et al. Among authors: poplack dg. Antimicrob Agents Chemother. 1988 Mar;32(3):324-6. doi: 10.1128/AAC.32.3.324. Antimicrob Agents Chemother. 1988. PMID: 2966610 Free PMC article.

6

Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys.

Arndt CA, Balis FM, McCully CL, Colvin OM, Poplack DG. Arndt CA, et al. Among authors: poplack dg. Cancer Res. 1988 Apr 15;48(8):2113-5. Cancer Res. 1988. PMID: 3349482

7

Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.

Collins JM, Klecker RW Jr, Kelley JA, Roth JS, McCully CL, Balis FM, Poplack DG. Collins JM, et al. Among authors: poplack dg. J Pharmacol Exp Ther. 1988 May;245(2):466-70. J Pharmacol Exp Ther. 1988. PMID: 3367302

8

Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate.

Heideman RL, McCully C, Balis FM, Poplack DG. Heideman RL, et al. Among authors: poplack dg. Invest New Drugs. 1993 May-Aug;11(2-3):135-40. doi: 10.1007/BF00874147. Invest New Drugs. 1993. PMID: 7505267

9

Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys.

Hawkins ME, Mitsuya H, McCully CM, Godwin KS, Murakami K, Poplack DG, Balis FM. Hawkins ME, et al. Among authors: poplack dg. Antimicrob Agents Chemother. 1995 Jun;39(6):1259-64. doi: 10.1128/AAC.39.6.1259. Antimicrob Agents Chemother. 1995. PMID: 7574512 Free PMC article.

10

Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey.

Berg SL, Balis FM, Godwin KS, Poplack DG. Berg SL, et al. Among authors: poplack dg. Invest New Drugs. 1993 Nov;11(4):255-61. doi: 10.1007/BF00874424. Invest New Drugs. 1993. PMID: 8157468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters